This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
Medicinal plants are plants with medicinal qualities or that have a positive pharmacological effect on the human or animal body. Medicinal herbs are used as an alternative and/or complementary medicine all over the world. Pharmacological and toxicological analyses of these medicinal plants are required for drug research and development. Medicinal plants have been utilised in medicine from the beginning of time. Global studies have been conducted to test their efficacy, with some of the findings leading to the development of plant-based medicines. The global industry for medical plant products is worth more than $100 billion each year. Medicinal plant material may come into contact with a variety of contaminants on its journey from the field to the shelf. Most pharmaceutical producers analyse medicinal plant material for bacterial and fungal residues before buying it; if the levels are higher than allowed, the product is rejected. Efforts should be directed toward measures that will improve the efficacy, effectiveness, and rational use of medicinal plants, particularly through integration into national, regional, and local health policies and programs.
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt